PERSPECTIVE article
Front. Aging
Sec. Healthy Longevity
Volume 6 - 2025 | doi: 10.3389/fragi.2025.1611959
This article is part of the Research TopicExploring Longevity: Insights and Research on Human Lifespan and HealthspanView all 6 articles
Implications of the Anti-Aging Efficacy of BaZi Bu Shen Capsules for Human Longevity and Development
Provisionally accepted
- Gansu University of Chinese Medicine, Lanzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
At present, there are no approved drugs for the treatment of aging, but a number of studies have reported related anti-aging drugs. As an innovative traditional Chinese medicine(TCM) that has been on the market for many years to treat waist and knees soreness, dizziness, tinnitus, fatigue, and cold limbs caused by insufficient kidney-yang, "Bazi Bushen Capsules (BZBS)" has also made a series of new and remarkable achievements in anti-aging research, which is expected to become the first new drug approved by the National Medical Products Administration(NMPA) for anti-aging indications, thus opening up new ideas for the medical field to treat aging. In the context of anti-aging, the general social phenomenon expected to be effectively caused is that people will enter a new era of longevity, and most countries will move from the current aging society to the aged society and even into the super-aging society in the near future. This remark provides forward-looking and guiding suggestions for future research on the relationship between longevity, economy and social protection.
Keywords: Bazi Bu Shen Capsules, anti-ageing drug, Future of mankind, Traditional Chinese Medicine, DNA methylation age
Received: 15 Apr 2025; Accepted: 10 Sep 2025.
Copyright: © 2025 Meng, Ma and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zuohuan Meng, Gansu University of Chinese Medicine, Lanzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.